MIB Daily Intelligence Brief
October 15, 2026 · 3 competitor signals detected
🔒 Confidential · Proprietary Business IntelligenceThis communication contains proprietary competitive intelligence prepared for Sunset Dermatology Group and its team. Please do not forward it outside your organization.
At a glance
- Bel Air Aesthetic Group: Botox per-unit price visible on website for first time — $11/unit
- Laurel Canyon Dermatology: Launched new "GLP-1 weight loss" service line targeting cosmetic patients
- Beverly Crest Dermatology: Five new reviews mention 4-month wait time for new patients
3 competitor signals detected for Sunset Dermatology Group today. One high-priority item warrants action this week.
🔴 HIGH PRIORITY
Botox per-unit price visible on website for first time — $11/unit
Bel Air Aesthetic Group added a pricing page yesterday with Botox at $11/unit (no minimums). This is unusual for the BH market where $13-15/unit is standard and pricing is normally not published. Likely a deliberate front-of-funnel acquisition move targeting price-shoppers who normally go to medspas.
→ Action: Don't race to the bottom on price. Counter with a "we don't up-sell units you don't need — every consult includes free imaging" message. Most price-shoppers convert to repeat clients when they trust the physician.
Sources: example.com
🟡 MEDIUM PRIORITY
Launched new "GLP-1 weight loss" service line targeting cosmetic patients
🌐 On their site
Laurel Canyon Dermatology added GLP-1 weight loss (semaglutide injection) as a new service yesterday. Pricing is $499/month membership. They are positioning it as a complement to cosmetic treatments — "skin tightening + weight management." Smart cross-sell into their existing aesthetic patient base.
→ Action: Assess whether GLP-1 fits your practice. The compounding regulatory environment is shifting; some dermatologists are exiting the space. If you do offer it, position around "physician-supervised, with proper medical oversight" — differentiator vs medspa-only practices.
Sources: example.com
🟡 📌
Beverly Crest Dermatology
MAPS ↗
Five new reviews mention 4-month wait time for new patients
Beverly Crest Dermatology has five reviews this week mentioning a "4-month wait" or "couldn't get in until October" for new patient consults. Indicates they're scheduling-constrained. Their unconverted demand is your opportunity.
→ Action: Run a Google Local Service Ad with "Available this week for new patient consults" copy. Target Rodeo Drive's search geo. Add a next-available-slot widget to your homepage so visitors see open slots rather than a "call to book" CTA.
Sources: maps.google.com
🟢 LOW PRIORITY / FYI
FDA expands semaglutide indication to include weight maintenance
The FDA approved an expanded indication for semaglutide yesterday, including weight maintenance after initial loss. Pharma marketing will amplify this; expect increased patient inquiries about long-term maintenance protocols.
→ Action: Train front-desk staff to handle GLP-1 maintenance inquiries even if you don't offer the service — refer to a partnering endocrinologist or medical weight-loss clinic. Lost trust from a hostile referral is expensive.
Sources: example.com
📎 .jsonl attached — feed today's brief to your AI agent
The attachment brief-*.jsonl
is a machine-readable version of this brief: one JSON object per change.
Save it and paste into ChatGPT/Claude/etc. with a prompt like
"Summarize the top 3 actions from this competitive brief."
Wiring your AI agent to read your inbox automatically is also an option — but it's a level of
access we don't recommend lightly. Inbox-reading agents have access to far more than this
brief; that's a risk only you can decide to accept.
Full guide & schema reference →
·
Schema docs
MyIntelBrief Competitive Intelligence
·
Manage account
·
Didn't ask for this? Unsubscribe
🔒 Confidential · Proprietary intelligence prepared exclusively for Sunset Dermatology Group · For your team only
Spotted something that looks wrong? Tell us at
info@myintelbrief.com (or via in-app Support) and we'll review and correct it promptly. AI-generated intelligence may contain errors; please verify before acting.